Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.
The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs. How can delays be avoided?
How is the business of making medicine changing in light of the COVID-19 pandemic?
How fakers are taking advantage of the pandemic.
How will the coronavirus impact manufacturing supply chains?
Could fluorescent silk proteins be the answer to the pharmaceutical industry's fake drug problem?
From improved supply chains to improved adherence, we explore how smart solutions can transform packaging – and the patient experience.
UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.
A collaboration for improved supply chain visibility.
Only when greater transparency is established in supply chains can the industry begin to iron out problems with drug shortages.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.